Clinical Trial Update: Delta-THC in Behavioral Disturbances in Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Delta-THC for behavioral disturbances in dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Delta-THC (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Dementia | Phase 2 | Status: COMPLETED